Literature DB >> 7615774

Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia.

J D Yao1, M Louie, L Louie, J Goodfellow, A E Simor.   

Abstract

Currently recommended dilution test methods for the determination of antimicrobial susceptibility of Stenotrophomonas (Xanthomonas) maltophilia are labor-intensive and often impractical in many clinical laboratories. We compared the E test with the agar dilution method for susceptibility testing of 176 clinical isolates of S. maltophilia against 16 antimicrobial agents. The MICs obtained by E test correlated well with those determined by the agar dilution method, with an overall agreement of 94%. Very major and major errors occurred infrequently (0.6 to 2.9%) when testing beta-lactam agents, tobramycin, trimethoprim-sulfamethoxazole, and fluoroquinolones. The E test was found to be accurate and easy to perform. For most antimicrobial agents tested against S. maltophilia, the E test is an acceptable alternative susceptibility test method.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7615774      PMCID： PMC228187          DOI： 10.1128/jcm.33.5.1428-1430.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.

Authors:  C N Baker; S A Stocker; D H Culver; C Thornsberry
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  The E-Test challenged with selected strains.

Authors:  D F Brown
Journal:  Diagn Microbiol Infect Dis       Date:  1992-07       Impact factor: 2.803

3.  Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients.

Authors:  M E Villarino; L E Stevens; B Schable; G Mayers; J M Miller; J P Burke; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1992-04       Impact factor: 3.254

4.  A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.

Authors:  S Vartivarian; E Anaissie; G Bodey; H Sprigg; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

5.  In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results.

Authors:  P Hohl; R Frei; P Aubry
Journal:  Diagn Microbiol Infect Dis       Date:  1991 Sep-Oct       Impact factor: 2.803

6.  Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum.

Authors:  R R Muder; V L Yu; J S Dummer; C Vinson; R M Lumish
Journal:  Arch Intern Med       Date:  1987-09

7.  Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983.

Authors:  N J Palleroni; J F Bradbury
Journal:  Int J Syst Bacteriol       Date:  1993-07

8.  Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.

Authors:  G A Pankuch; M R Jacobs; S F Rittenhouse; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

9.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

Review 10.  Xanthomonas maltophilia: an emerging nosocomial pathogen.

Authors:  W F Marshall; M R Keating; J P Anhalt; J M Steckelberg
Journal:  Mayo Clin Proc       Date:  1989-09       Impact factor: 7.616
View more
  10 in total

1.  Molecular identification by 16S rDNA sequencing using excised corneal tissues: a useful diagnostic tool for refractory keratitis.

Authors:  Pinnita Prabhasawat; Amornrut Leelaporn; Nattaporn Tesavibul; Mongkol Uiprasertkul; Chareenun Chirapapaisan
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

2.  Multiple antibiotic resistance in Stenotrophomonas maltophilia.

Authors:  A Alonso; J L Martínez
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 3.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 4.  Antimicrobial therapy for Stenotrophomonas maltophilia infections.

Authors:  A C Nicodemo; J I Garcia Paez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-04       Impact factor: 3.267

5.  In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.

Authors:  J L Muñoz Bellido; S Muñoz Criado; I García García; M A Alonso Manzanares; M N Gutiérrez Zufiaurre; J A García-Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

6.  Antimicrobial susceptibility of Helicobacter pylori determined by the E test using tetrazolium egg yolk agar.

Authors:  Y Valdez; B Velapatiño; R H Gilman; V Gutierrez; C León
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

7.  Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories.

Authors:  Giovanni Pietro Gesu; Federico Marchetti; Laura Piccoli; Annalisa Cavallero
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Selection of small-colony variants of Salmonella enterica serovar typhimurium in nonphagocytic eucaryotic cells.

Authors:  David A Cano; M Graciela Pucciarelli; Marina Martínez-Moya; Josep Casadesús; Francisco García-del Portillo
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness.

Authors:  Müserref Tatman-Otkun; Saban Gürcan; Burçin Ozer; Bayram Aydoslu; Sebnem Bukavaz
Journal:  BMC Microbiol       Date:  2005-05-09       Impact factor: 3.605

10.  Clinical Features and Management of Stenotrophomonas Maltophilia Keratitis.

Authors:  B-C Park; Hwa-Rang Lim; Seon-Joo Park; Jae-Woong Koh
Journal:  Ophthalmol Ther       Date:  2021-05-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.